Dupitumacon (Duplexan)
Product detail for Dupitumacon, INN: dupitumacon. Therapeutic area: Immunology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-006
INN
dupitumacon
Therapeutic Area
Immunology
Status
Active
Owner
Marcus Webb
Created
2022-08-13
Last Updated
2023-07-01
Markets
3
Presentations
| Form | Strength | Route |
|---|---|---|
| Hard capsule | 400 mg | Intramuscular |
| Oral solution | 200 mg | Subcutaneous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-014 | Glucovantib | glucovantib | 23263-42-2 | biologic | Active |
| SUB-017 | Thymosilib | thymosilib | 94484-27-2 | biologic | Active |
Applications (4)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| HC-2024-0006 | Canada | sNDA | Active | Priya Sharma | 2022-05-08 |
| TITCK-2024-0036 | Canada | Type IB Variation | Active | Sarah Chen | 2023-09-16 |
| HC-2024-0066 | Canada | sBLA | Submitted | Lieselotte van der Berg | 2023-09-28 |
| TITCK-2024-0096 | Canada | Type IB Variation | Blocked | Marcus Webb | 2023-07-22 |
Markets (3)